|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 211/22 | (2006.01) |
| A61K 31/4409 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2358675 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09752688.3 |
| Date of filing the European patent application | 2009-11-13 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-03 |
| (46) | Date of publication of the claims translation | 2013-03-25 |
| (86) | Number | PCT/US2009/064308 |
| Date | 2009-11-13 |
| (87) | Number | WO 2010/056941 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 114541 P | 2008-11-14 | US |
| (72) |
PATTERSON, Lori Jean, US
STANGELAND, Eric L., US
ZIPFEL, Sheila, US
LONG, Daniel D., US
|
| (73) |
Theravance Biopharma R&D IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4-[2-(2-Fluorfenoksimetil)fenil]piperidino junginiai |
| 4-[2-(2-Fluorophenoxymethyl)phenyl]piperidine compounds |
| Payment date | Validity (years) | Amount | |
| 2024-10-21 | 16 | 347.00 EUR |
| 2025-11-13 |